UB Paderborn / Katalog / Suche / in CDI

Synthesis and Initial SAR Studies of 3,6-Disubstituted Pyrazolo[1,5- a]pyrimidines: A New Class of KDR Kinase Inhibitors

Bioorganic & medicinal chemistry letters, 2002-10, Vol.12 (19), p.2767-2770

2002

Volltextzugriff (PDF)

Optimization of a pyrazolo[1,5- a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics

Bioorganic & medicinal chemistry letters, 2002-12, Vol.12 (24), p.3537-3541

2002

Volltextzugriff (PDF)

Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG binding

Bioorganic & medicinal chemistry letters, 2004-01, Vol.14 (2), p.351-355

2004

Volltextzugriff (PDF)

Property-based design of KDR kinase inhibitors

Current medicinal chemistry, 2004-03, Vol.11 (6), p.709

2004

Volltextzugriff (PDF)

The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase

Bioorganic & medicinal chemistry letters, 2004-06, Vol.14 (11), p.2941-2945

2004

Volltextzugriff (PDF)

2,4-Disubstituted pyrimidines: A novel class of KDR kinase inhibitors

Bioorganic & medicinal chemistry letters, 2003-05, Vol.13 (10), p.1673-1677

2003

Volltextzugriff (PDF)

Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDR

Bioorganic & medicinal chemistry letters, 2003-08, Vol.13 (15), p.2485-2488

2003

Volltextzugriff (PDF)

Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors

Bioorganic & medicinal chemistry letters, 2003-09, Vol.13 (18), p.2973-2976

2003

Volltextzugriff (PDF)

Effects of L-749,329, an ETA/ETB endothelin receptor antagonist, in a porcine coronary artery injury model of vascular restenosis

Circulation (New York, N.Y.), 2001-04, Vol.103 (14), p.1899-1905

2001

Volltextzugriff (PDF)

Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells

The Journal of biological chemistry, 1991-05, Vol.266 (15), p.9419-9427

1991

Volltextzugriff (PDF)

Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors

Bioorganic & medicinal chemistry letters, 2004-01, Vol.14 (2), p.351-355

2004

Volltextzugriff (PDF)

Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosis

Circulation (New York, N.Y.), 1996-03, Vol.93 (5), p.1009-1019

1996

Volltextzugriff (PDF)

Smooth muscle cells isolated from the neointima after vascular injury exhibit altered responses to platelet-derived growth factor and other stimuli

Journal of cellular physiology, 1996-04, Vol.167 (1), p.106-112

1996

Volltextzugriff (PDF)

Effects of L-749,329, an ET A /ET B Endothelin Receptor Antagonist, in a Porcine Coronary Artery Injury Model of Vascular Restenosis

Circulation (New York, N.Y.), 2001-04, Vol.103 (14), p.1899-1905

2001

Volltextzugriff (PDF)

Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors: Recent advances in the design of kinase inhibitors as novel therapeutic agents

Bioorganic & medicinal chemistry letters, 2003, Vol.13 (18), p.2973-2976

2003

Volltextzugriff (PDF)

Discovery and evaluation of 3-(5-Thien-3-ylpyridin-3-yl)-1 H-indoles as a novel class of KDR kinase inhibitors

Bioorganic & medicinal chemistry letters, 2003, Vol.13 (18), p.2973-2976

2003

Volltextzugriff (PDF)

Scanning electron microscopic observation of two retinoblastoma cell lines

Cancer research (Chicago, Ill.), 1978-09, Vol.38 (9), p.2827-2835

1978

Volltextzugriff (PDF)

Characterization of a new continuous cell line derived from a human retinoblastoma

Cancer research (Chicago, Ill.), 1977-04, Vol.37 (4), p.1003-1010

1977

Volltextzugriff (PDF)

Metastatic choroidal melanoma. Hepatic binding protein reactivity toward a liver-metastasizing clone

Archives of ophthalmology (1960), 1983-05, Vol.101 (5), p.787

1983

Volltextzugriff (PDF)

Pharmacological and mechanistic aspects concerning the use of heparin and β-cyclodextrin tetradecasulfate for the treatment of vascular restenosis

Drug development research, 1993-06, Vol.29 (2), p.137-147

1993

Volltextzugriff (PDF)

2,4-Disubstituted Pyrimidines: A Novel Class of KDR Kinase Inhibitors

ChemInform, 2003-09, Vol.34 (37), p.no-no

2003

Volltextzugriff (PDF)

A method for the isolation of t lymphocytes from normal and neoplastic ocular tissue

Journal of Tissue Culture Methods, 1982-12, Vol.7 (4), p.147-149

1982

Volltextzugriff (PDF)

Scanning electron microscope study of herpes simplex virus experimental disciform keratitis

British journal of ophthalmology, 1978-12, Vol.62 (12), p.838-842

1978

Volltextzugriff (PDF)

Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling

Molecular cancer therapeutics, 2005-03, Vol.4 (3), p.413-425

2005

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Synthesis and Initial SAR Studies of 3,6-Disubstituted Pyrazolo[1,5- a]pyrimidines: A New Class of KDR Kinase Inhibitors

Optimization of a pyrazolo[1,5- a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics

Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG binding

Property-based design of KDR kinase inhibitors

The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase

2,4-Disubstituted pyrimidines: A novel class of KDR kinase inhibitors

Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDR

Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors

Effects of L-749,329, an ETA/ETB endothelin receptor antagonist, in a porcine coronary artery injury model of vascular restenosis

Potent N-(1,3-Thiazol-2-yl)pyridin-2-amine Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors with Excellent Pharmacokinetics and Low Affinity for the hERG Ion Channel

Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells

Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors

Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosis

Smooth muscle cells isolated from the neointima after vascular injury exhibit altered responses to platelet-derived growth factor and other stimuli

Effects of L-749,329, an ET A /ET B Endothelin Receptor Antagonist, in a Porcine Coronary Artery Injury Model of Vascular Restenosis

Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors: Recent advances in the design of kinase inhibitors as novel therapeutic agents

Discovery and evaluation of 3-(5-Thien-3-ylpyridin-3-yl)-1 H-indoles as a novel class of KDR kinase inhibitors

Scanning electron microscopic observation of two retinoblastoma cell lines

Characterization of a new continuous cell line derived from a human retinoblastoma

Metastatic choroidal melanoma. Hepatic binding protein reactivity toward a liver-metastasizing clone

Pharmacological and mechanistic aspects concerning the use of heparin and β-cyclodextrin tetradecasulfate for the treatment of vascular restenosis

2,4-Disubstituted Pyrimidines: A Novel Class of KDR Kinase Inhibitors

A method for the isolation of t lymphocytes from normal and neoplastic ocular tissue

Scanning electron microscope study of herpes simplex virus experimental disciform keratitis

Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling

Suchergebnisse filtern